Overview of Ipsen's Voting Rights in January 2025
Ipsen, a key player in the biopharmaceutical industry, continuously updates its stakeholders about the status of its voting rights and share capital. This commitment ensures transparency and compliance with regulatory requirements set forth in the French Commercial Code and by the Autorité des Marchés Financiers. In January 2025, Ipsen provided vital insights into the total number of voting rights and the number of shares in circulation.
Key Information on Shares and Voting Rights
According to recent disclosures, Ipsen is listed on Euronext Paris, and its ISIN code is FR 0010259150, with a Legal Entity Identifier (LEI) of 549300M6SGDPB4Z94P11. These identifiers play a crucial role in validating transactions and ensuring the organization adheres to financial regulations.
January 2025 Data Summary
As of January 31, 2025, Ipsen reported a total of 83,814,526 shares making up its capital. Notably, the gross total of voting rights available is recorded at 131,933,045, whereas the net total comes in slightly lower at 130,834,730. The distinction between gross and net totals is paramount; the gross total includes all shares, even those with double voting rights, and treasury shares, while the net total accounts solely for those shares that actively carry voting rights.
Understanding Voting Rights Calculations
The way voting rights are calculated significantly impacts shareholder decision-making processes. The gross total reflects the entire spectrum of shares, while the net total highlights the active voting capabilities among shareholders. This data is critical, as it informs the company's governance practices and the engagement of its investors.
Significance of Ipsen's Reporting
Regular updates on share capital and voting rights serve more than a regulatory purpose; they foster investor confidence and promote an engaged shareholder base. A clear understanding of these metrics helps investors make informed decisions regarding their holdings and influence company governance.
Regulatory Compliance
Reporting such information is not just a matter of corporate governance; it is mandated by the French Commercial Code. Ipsen adheres to these legal frameworks around threshold crossings, ensuring that all stakeholders are aware of any significant changes influencing their rights as shareholders.
Frequently Asked Questions
What is Ipsen's ISIN code?
Ipsen's ISIN code is FR 0010259150.
How many shares does Ipsen have in circulation as of January 2025?
As of January 31, 2025, Ipsen has 83,814,526 shares in circulation.
What is the significance of gross and net voting rights?
Gross voting rights include all shares, while net voting rights exclude shares without voting rights, offering a clear view of active shareholder engagement.
Why is Ipsen required to disclose voting rights information?
Disclosures are mandated by the French Commercial Code to ensure transparency and inform stakeholders about their voting powers.
What is the LEI of Ipsen?
Ipsen's Legal Entity Identifier (LEI) is 549300M6SGDPB4Z94P11.
